QQQ   445.12 (+0.07%)
AAPL   171.26 (-1.18%)
MSFT   421.06 (-0.09%)
META   489.86 (-0.81%)
GOOGL   150.75 (-0.08%)
AMZN   181.21 (+0.77%)
TSLA   176.88 (-1.64%)
NVDA   906.99 (+0.50%)
NIO   4.69 (+0.43%)
AMD   180.63 (+0.58%)
BABA   72.25 (+0.92%)
T   17.57 (+0.11%)
F   13.22 (+1.23%)
MU   117.63 (-1.27%)
CGC   9.33 (-2.30%)
GE   177.24 (-1.60%)
DIS   123.49 (+2.07%)
AMC   3.81 (-12.21%)
PFE   27.78 (+0.00%)
PYPL   66.53 (-0.06%)
XOM   115.23 (+0.23%)
QQQ   445.12 (+0.07%)
AAPL   171.26 (-1.18%)
MSFT   421.06 (-0.09%)
META   489.86 (-0.81%)
GOOGL   150.75 (-0.08%)
AMZN   181.21 (+0.77%)
TSLA   176.88 (-1.64%)
NVDA   906.99 (+0.50%)
NIO   4.69 (+0.43%)
AMD   180.63 (+0.58%)
BABA   72.25 (+0.92%)
T   17.57 (+0.11%)
F   13.22 (+1.23%)
MU   117.63 (-1.27%)
CGC   9.33 (-2.30%)
GE   177.24 (-1.60%)
DIS   123.49 (+2.07%)
AMC   3.81 (-12.21%)
PFE   27.78 (+0.00%)
PYPL   66.53 (-0.06%)
XOM   115.23 (+0.23%)
QQQ   445.12 (+0.07%)
AAPL   171.26 (-1.18%)
MSFT   421.06 (-0.09%)
META   489.86 (-0.81%)
GOOGL   150.75 (-0.08%)
AMZN   181.21 (+0.77%)
TSLA   176.88 (-1.64%)
NVDA   906.99 (+0.50%)
NIO   4.69 (+0.43%)
AMD   180.63 (+0.58%)
BABA   72.25 (+0.92%)
T   17.57 (+0.11%)
F   13.22 (+1.23%)
MU   117.63 (-1.27%)
CGC   9.33 (-2.30%)
GE   177.24 (-1.60%)
DIS   123.49 (+2.07%)
AMC   3.81 (-12.21%)
PFE   27.78 (+0.00%)
PYPL   66.53 (-0.06%)
XOM   115.23 (+0.23%)
QQQ   445.12 (+0.07%)
AAPL   171.26 (-1.18%)
MSFT   421.06 (-0.09%)
META   489.86 (-0.81%)
GOOGL   150.75 (-0.08%)
AMZN   181.21 (+0.77%)
TSLA   176.88 (-1.64%)
NVDA   906.99 (+0.50%)
NIO   4.69 (+0.43%)
AMD   180.63 (+0.58%)
BABA   72.25 (+0.92%)
T   17.57 (+0.11%)
F   13.22 (+1.23%)
MU   117.63 (-1.27%)
CGC   9.33 (-2.30%)
GE   177.24 (-1.60%)
DIS   123.49 (+2.07%)
AMC   3.81 (-12.21%)
PFE   27.78 (+0.00%)
PYPL   66.53 (-0.06%)
XOM   115.23 (+0.23%)
NASDAQ:BCAC

Brookline Capital Acquisition (BCAC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$9.94
$27.74
50-Day Range
$0.36
$22.71
52-Week Range
$9.50
$27.74
Volume
586,400 shs
Average Volume
39,682 shs
Market Capitalization
$153.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BCAC stock logo

About Brookline Capital Acquisition Stock (NASDAQ:BCAC)

Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.

BCAC Stock News Headlines

Q2 2023 electroCore, Inc. Earnings Call
The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
LFAC LF Capital Acquisition Corp. II
Apexigen Announces Board Appointment and New Chair
The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
Brookline Capital Acquisition Corp.
See More Headlines
Receive BCAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:BCAC
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
$-480,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
5,451,000
Market Cap
$153.20 million
Optionable
Not Optionable
Beta
-0.03
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Samuel P. Wertheimer Ph.D.
    Chairman & CEO
  • Mr. Scott A. Katzmann (Age 66)
    Pres & Director
  • Mr. Patrick Sturgeon
    Chief Financial Officer

This page (NASDAQ:BCAC) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners